BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 14678300)

  • 1. Cushing's disease as the first clinical manifestation of multiple endocrine neoplasia type 1 (MEN1) associated with an R460X mutation of the MEN1 gene.
    Matsuzaki LN; Canto-Costa MH; Hauache OM
    Clin Endocrinol (Oxf); 2004 Jan; 60(1):142-3. PubMed ID: 14678300
    [No Abstract]   [Full Text] [Related]  

  • 2. Cushing's disease in childhood as the first manifestation of multiple endocrine neoplasia syndrome type 1.
    Rix M; Hertel NT; Nielsen FC; Jacobsen BB; Hoejberg AS; Brixen K; Hangaard J; Kroustrup JP
    Eur J Endocrinol; 2004 Dec; 151(6):709-15. PubMed ID: 15588237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expressions of Cushing's syndrome in multiple endocrine neoplasia type 1.
    Simonds WF
    Front Endocrinol (Lausanne); 2023; 14():1183297. PubMed ID: 37409236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cushing's disease in two sisters.
    Gardner DF; Barlascini CO; Downs RW; Sahni KS
    Am J Med Sci; 1989 Jun; 297(6):387-9. PubMed ID: 2544092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cushing's syndrome in multiple endocrine neoplasia type 1.
    Simonds WF; Varghese S; Marx SJ; Nieman LK
    Clin Endocrinol (Oxf); 2012 Mar; 76(3):379-86. PubMed ID: 21916912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis by serendipity: Cushing syndrome attributable to cortisol-producing adrenal adenoma as the initial manifestation of multiple endocrine neoplasia type 1 due to a rare splicing site MEN1 gene mutation.
    Alzahrani AS; Al-Khaldi N; Shi Y; Al-Rijjal RA; Zou M; Baitei EY; Amin T
    Endocr Pract; 2008; 14(5):595-602. PubMed ID: 18753104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
    Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
    Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of primary hyperparathyroidism, primary hyperaldosteronism and Cushing's disease.
    Herd GW
    Acta Endocrinol (Copenh); 1984 Nov; 107(3):371-4. PubMed ID: 6150593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of Cushing's syndrome.
    Yaneva M; Vandeva S; Zacharieva S; Daly AF; Beckers A
    Neuroendocrinology; 2010; 92 Suppl 1():6-10. PubMed ID: 20829611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ectopic Cushing syndrome associated with thymic carcinoid tumor as the first presentation of MEN1 syndrome-report of a family with MEN1 gene mutation.
    Hasani-Ranjbar S; Rahmanian M; Ebrahim-Habibi A; Soltani A; Soltanzade A; Mahrampour E; Amoli MM
    Fam Cancer; 2014 Jun; 13(2):267-72. PubMed ID: 24218143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple endocrine neoplasia type 1Burin from Mauritius: a novel MEN1 mutation.
    Kong C; Ellard S; Johnston C; Farid NR
    J Endocrinol Invest; 2001 Nov; 24(10):806-10. PubMed ID: 11765051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cushing's disease and craniopharyngioma.
    Ackland FM; Stanhope R; Preece MA
    Arch Dis Child; 1987 Oct; 62(10):1077-8. PubMed ID: 2823728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple endocrine neoplasia type I and Cushing's syndrome due to an aggressive ACTH producing thymic carcinoid.
    Takagi J; Otake K; Morishita M; Kato H; Nakao N; Yoshikawa K; Ikeda H; Hirooka Y; Hattori Y; Larsson C; Nogimori T
    Intern Med; 2006; 45(2):81-6. PubMed ID: 16484744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary ACTH dependency of nodular adrenal hyperplasia in Cushing's syndrome. Report of two cases and review of the literature.
    Aron DC; Findling JW; Fitzgerald PA; Brooks RM; Fisher FE; Forsham PH; Tyrrell JB
    Am J Med; 1981 Aug; 71(2):302-6. PubMed ID: 6266251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cushing's disease revisited.
    Wilson CB; Tyrrell JB; Fitzgerald P
    Am J Surg; 1979 Jul; 138(1):77-9. PubMed ID: 223465
    [No Abstract]   [Full Text] [Related]  

  • 16. Pro-opiomelanocortin gene expression in silent corticotroph-cell adenoma and Cushing's disease.
    Nagaya T; Seo H; Kuwayama A; Sakurai T; Tsukamoto N; Nakane T; Sugita K; Matsui N
    J Neurosurg; 1990 Feb; 72(2):262-7. PubMed ID: 2153197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neurosurgical management of Cushing's disease.
    Reitmeyer M; Vance ML; Laws ER
    Mol Cell Endocrinol; 2002 Nov; 197(1-2):73-9. PubMed ID: 12431799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple Endocrine Neoplasia Type 1 with Functional Parathyroid Cysts.
    Koyama N; Nagase T; Kure M; Odaka T; Kogure K; Takeda Y; Ishii T; Narisawa K; Fujita T; Fujimori M; Katsura Y
    Intern Med; 2022 Apr; 61(8):1183-1188. PubMed ID: 34645755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cushing's syndrome in patients with the Zollinger-Ellison syndrome.
    Maton PN; Gardner JD; Jensen RT
    N Engl J Med; 1986 Jul; 315(1):1-5. PubMed ID: 2872593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MEN1 and pituitary adenomas.
    Delemer B
    Ann Endocrinol (Paris); 2012 Apr; 73(2):59-61. PubMed ID: 22542456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.